Goldman Sachs’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Goldman Sachs’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-21,655	Closed	-$275K	–	7579
2014 Q3	$275K	Buy	21,655 +14,970	+224%	+$224K	﹤0.01%	5843
2014 Q2	$114K	Buy	+6,685	New	+$99.5K	﹤0.01%	6504
2013 Q4	–	Sell	-18,609	Closed	-$168K	–	6943
2013 Q3	$168K	Sell	18,609 -414,325	-96%	-$3.44M	﹤0.01%	5968
2013 Q2	$3.12M	Buy	+432,934	New	+$3.18M	﹤0.01%	3237

Goldman Sachs's DRTX Position: Q4 2014 in Review

Goldman Sachs sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 21,655 shares — an estimated $275K sold.

Goldman Sachs first reported a position in DRTX in Q2 2013 and held it in 4 quarters. The position peaked at $3.12M in Q2 2013. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Goldman Sachs reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Goldman Sachs sold 21,655 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $275K.
Goldman Sachs first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
Goldman Sachs's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $3.12M in Q2 2013.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Goldman Sachs's 13F filing for Q4 2014, filed 13 Feb 2015.